phloroglucinol

Preferred Label : phloroglucinol;

MeSH definition : A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.;

MeSH synonym : Benzene-1,3,5-triol; 1,3,5-Benzenetriol;

CISMeF synonym : irex brand of phloroglucinol; lafon brand of phloroglucinol;

MeSH hyponym : Spasfon-Lyoc; spassirex;

MeSH CAS label : 1,3,5-Benzenetriol;

MeSH Related Number : 108-73-6 (Phloroglucinol);

Registry Number MeSH : 108-73-6;

Wikipedia link : https://en.wikipedia.org/wiki/Phloroglucinol;

Codes EINECS : 203-611-2;

Is substance : O;

medicament (CISMeF) : O;

UNII : DHD7FFG6YS;

InChIKey : QCDYQQDYXPDABM-UHFFFAOYSA-N;

Details

Origin ID

D010696;

UMLS CUI

C0031566;

ATC code(s)
- phloroglucinol [ATC Code]
ATC code(s)
- phloroglucinol [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Phloroglucinol [ICD-11 Extension code]
CISMeF manual mappings
- Phloroglucinol (substance) [SNOMED CT concept]
- phloroglucinol [Substance BNPC]
Exact mapping(s) to DCI
- phloroglucinol [International Nonproprietary Name]
Pharmacological action(s)
- indicators and reagents [MeSH Descriptor]
Record concept(s)
- Spasfon-Lyoc [MeSH concept]
- phloroglucinol [MeSH concept]
- spassirex [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1S,32R,5S,6R,7R)-6-((R)-3,4-di-hydroxy-4-methylpentyl)-2-(2-hydroxypropan-2-yl)-7-isobutyryl-6-methyl-5,9-bis(3-methylbut-2-en-1-yl)-4,5,6,7-tetrahydro-2H-32,7-methanocycloocta(b)furan-8,10(3H)-dione [MeSH Supplementary Concept]
- (4R,5R,7R)-4-((R)-3,4-dihydroxy-4-methylpentyl)-2,2,4-trimethyl-5,7-bis(3-methyl-but-2-en-1-yl)-7-(5-methylhex-4-enoyl)-4,5,6,7-tetrahydrobenzofuran-3(2H)-one [MeSH Supplementary Concept]
- (beta-D-glucosyl)3 yariv phenylglycoside [MeSH Supplementary Concept]
- (beta-D-mannosyl)3 yariv phenylglycoside [MeSH Supplementary Concept]
- 1,1'-(2,4,6-trihydroxy-1,3-phenylene)bis(butan-1-one) [MeSH Supplementary Concept]
- 1,3,5-benzenetriol, 1,3,5-trimethoxybenzene drug combination [MeSH Supplementary Concept]
- 1,3,5-triformylphloroglucinol [MeSH Supplementary Concept]
- 1,3,5-trihydroxy-6-(2''',3'''-epoxy-3'''-methyl-butyl)-2-(2''-methyl-butanoyl)-4-(3'-methyl-2''-butenyl)-benzene [MeSH Supplementary Concept]
- 1,3,5-trimethoxybenzene [MeSH Supplementary Concept]
- 1-((3-methylbutanoyl)phloroglucinyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 1-((pentanoyl)phloroglucinyl)-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 1-(3',5'-dihydroxyphenoxy)-7-(2'',4'',6''-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4,-dioxin [MeSH Supplementary Concept]
- 1-(3',5'-dihydroxyphenoxy)-7-(2',4',6-trihydroxyphenoxy)-2,4,9-trihydroxydibenzo-1,4-dioxin [MeSH Supplementary Concept]
- 1-(3,5-bis-(3-acetyl-2,6-dihydroxy-4-methoxy-benzyl)-2,4,6-trihydroxy-phenyl)-ethanone [MeSH Supplementary Concept]
- 1-(3-isopentanoyl-5-((3,5-diisopentanoyl-2,4,6-trihydroxyphenyl)-4-benzyloxyphenylmethyl)-2,4,6-trihydroxyphenyl)-3-methylbutan-1-one [MeSH Supplementary Concept]
- 1-(3-isopentanoyl-5-((3,5-diisopentanoyl-2,4,6-trihydroxyphenyl)-phenylmethyl)-2,4,6-trihydroxyphenyl)-3-methylbutan-1-one [MeSH Supplementary Concept]
- 1-(hexanoyl)phloroglucinol-alpha-D-arabinopyranoside [MeSH Supplementary Concept]
- 1-(hexanoyl)phloroglucinol-beta-D-glucopyranoside [MeSH Supplementary Concept]
- 1-O-beta-D-(2,4-dihydroxy-6-methoxyphenyl)-6-O-(4-hydroxy-3,5-dimethoxybenzoyl)-glucopyranoside [MeSH Supplementary Concept]
- 2,2'-ethylidenediphloroglucinol [MeSH Supplementary Concept]
- 2,4,6-trihydroxy-3-geranylacetophenone [MeSH Supplementary Concept]
- 2,4-bis(2-fluorophenylacetyl)phloroglucinol [MeSH Supplementary Concept]
- 2,4-bis(4-fluorophenylacetyl)phloroglucinol [MeSH Supplementary Concept]
- 2,4-diacetylphloroglucinol [MeSH Supplementary Concept]
- 2,7''-phloroglucinol-6,6'-bieckol [MeSH Supplementary Concept]
- 2-((4-fluorophenylimino)methyl)-3,5-dimethoxyphenol [MeSH Supplementary Concept]
- 2-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-4-(3-methylbut-2-en-1-yl)-3,6-dioxocyclohexa-1,4-dien-1-yl isobutyrate [MeSH Supplementary Concept]
- 2-methyl-1-(2,4,6-trihydroxy-3,5-di(3-methyl-2-butenyl)phenyl)-1-propanone [MeSH Supplementary Concept]
- 2-methyl-1-(2,4,6-trihydroxy-3-(3-methyl2-butenyl)phenyl)-1-propanone [MeSH Supplementary Concept]
- 2-methyl-1-(2,4,6-trihydroxyphenyl)-1-propanone [MeSH Supplementary Concept]
- 2-methyl-4-(2',4',6'-trihydroxy-3'-(2-methylpropanoyl)phenyl)but-3-enyl acetate [MeSH Supplementary Concept]
- 2-nitrophloroglucinol [MeSH Supplementary Concept]
- 3,3'-diacetyl-2,4'-dimethoxy-2',4,6,6'-tetrahydroxy-5'-methyl diphenylmethane [MeSH Supplementary Concept]
- 3-C-glucopyranosyl-5-methylphloroacetophenone [MeSH Supplementary Concept]
- 3-hydroxy-2-((2,4,6-trimethoxybenzyl)amino)propanoic acid [MeSH Supplementary Concept]
- 4,6-dihydroxy-5-(3-methylbutyryl)-3-(2-oxopropyl)-3-(2,4,6-trihydroxy-3-(3-methylbutyryl)benzyl)-2,3-dihydrobenzo(b)furan-2-one [MeSH Supplementary Concept]
- 4-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(3-methylbut-2-en-1-yl)-3,6-dioxocyclohexa-1,4-dien-1-yl 2-methylbutanoate [MeSH Supplementary Concept]
- 4-(3,7-dimethylocta-2,6-dien-1-yl)-5-hydroxy-2-(3-methylbut-2-en-1-yl)-3,6-dioxocyclohexa-1,4-dien-1-yl isobutyrate [MeSH Supplementary Concept]
- 4-geranyloxy-1-(2-methylbutanoyl)phloroglucinol [MeSH Supplementary Concept]
- 4-geranyloxy-1-(2-methylpropanoyl)phloroglucinol [MeSH Supplementary Concept]
- 4-geranyloxy-2,6-dihydroxybenzophenone [MeSH Supplementary Concept]
- 5-(4-N-(N-2',6'-dinitro-4'-trifluoromethylphenyl)aminophenyl)-10,15,20-tris(2,4,6-trimethoxyphenyl)porphyrin [MeSH Supplementary Concept]
- 5-deprenyllupulonol C [MeSH Supplementary Concept]
- BF-1 compound [MeSH Supplementary Concept]
- IC 261 [MeSH Supplementary Concept]
- adotogirin [MeSH Supplementary Concept]
- alpha-kosin [MeSH Supplementary Concept]
- andinin A [MeSH Supplementary Concept]
- androforin A [MeSH Supplementary Concept]
- anthuminoate [MeSH Supplementary Concept]
- anthuminone [MeSH Supplementary Concept]
- aristoforin [MeSH Supplementary Concept]
- arzanol [MeSH Supplementary Concept]
- aspidin BB [MeSH Supplementary Concept]
- aspidin PB [MeSH Supplementary Concept]
- austrobrasilol A [MeSH Supplementary Concept]
- austrobrasilol B [MeSH Supplementary Concept]
- baeckenone F [MeSH Supplementary Concept]
- bis-(10-deoxydihydroartemisinin)-phloroglucinol [MeSH Supplementary Concept]
- bullataketal A [MeSH Supplementary Concept]
- calix(4)phloroglucinarene dodecamethyl ether [MeSH Supplementary Concept]
- callistrilone A [MeSH Supplementary Concept]
- callistrilone B [MeSH Supplementary Concept]
- corymbone A [MeSH Supplementary Concept]
- corymbone B [MeSH Supplementary Concept]
- denudatin A [MeSH Supplementary Concept]
- deoxycohumulone [MeSH Supplementary Concept]
- dioxasampsone A [MeSH Supplementary Concept]
- dioxasampsone D [MeSH Supplementary Concept]
- elaphopilosin-A [MeSH Supplementary Concept]
- elaphopilosin-B [MeSH Supplementary Concept]
- elliptophenone A [MeSH Supplementary Concept]
- erectquione A [MeSH Supplementary Concept]
- erectquione B [MeSH Supplementary Concept]
- erectquione C [MeSH Supplementary Concept]
- eucalyptone [MeSH Supplementary Concept]
- eucarobustol E [MeSH Supplementary Concept]
- euglobal G1 [MeSH Supplementary Concept]
- euglobal G2 [MeSH Supplementary Concept]
- euglobal G3 [MeSH Supplementary Concept]
- euglobal R1 [MeSH Supplementary Concept]
- euglobal R2 [MeSH Supplementary Concept]
- euglobal in 1 [MeSH Supplementary Concept]
- ficifolidione [MeSH Supplementary Concept]
- furohyperforin [MeSH Supplementary Concept]
- garcimulin A [MeSH Supplementary Concept]
- garcimulin B [MeSH Supplementary Concept]
- garcimultiflorone D [MeSH Supplementary Concept]
- garcimultiflorone K [MeSH Supplementary Concept]
- guttiferone G [MeSH Supplementary Concept]
- helichrytalicine A [MeSH Supplementary Concept]
- helichrytalicine B [MeSH Supplementary Concept]
- helichrytalicine C [MeSH Supplementary Concept]
- hyperandrone A [MeSH Supplementary Concept]
- hyperatomarin [MeSH Supplementary Concept]
- hyperattenin L [MeSH Supplementary Concept]
- hyperattenin M [MeSH Supplementary Concept]
- hyperciumoxide N [MeSH Supplementary Concept]
- hyperforatin G [MeSH Supplementary Concept]
- hyperforatin H [MeSH Supplementary Concept]
- hyperforin [MeSH Supplementary Concept]
- hyperforin, N,N-dicyclohexylamine salt [MeSH Supplementary Concept]
- hyperibrin E [MeSH Supplementary Concept]
- hyperibrin F [MeSH Supplementary Concept]
- hyperibrin G [MeSH Supplementary Concept]
- hyperielliptone HA [MeSH Supplementary Concept]
- hyperinakin [MeSH Supplementary Concept]
- hyperisampsin A [MeSH Supplementary Concept]
- hyperisampsin D [MeSH Supplementary Concept]
- hyperjovinol A [MeSH Supplementary Concept]
- hyperjovinol B [MeSH Supplementary Concept]
- hypermongone G [MeSH Supplementary Concept]
- hyperscabrin A [MeSH Supplementary Concept]
- hyperscabrin B [MeSH Supplementary Concept]
- hyperscabrin C [MeSH Supplementary Concept]
- hypersubone A [MeSH Supplementary Concept]
- hypersubone B [MeSH Supplementary Concept]
- hyperuralone A [MeSH Supplementary Concept]
- hyperuralone B [MeSH Supplementary Concept]
- indigoferin-C [MeSH Supplementary Concept]
- isoaustrobrasilol B [MeSH Supplementary Concept]
- isomallotochromanol [MeSH Supplementary Concept]
- isomallotolerin [MeSH Supplementary Concept]
- jensenone [MeSH Supplementary Concept]
- kielmeyeracin [MeSH Supplementary Concept]
- kosotoxin [MeSH Supplementary Concept]
- kunzeaphlogin A [MeSH Supplementary Concept]
- lawsoniaside A [MeSH Supplementary Concept]
- laxifloranone [MeSH Supplementary Concept]
- leptospermone [MeSH Supplementary Concept]
- loxophlebal A [MeSH Supplementary Concept]
- loxophlebal B [MeSH Supplementary Concept]
- loxophlebene [MeSH Supplementary Concept]
- lysidicin A [MeSH Supplementary Concept]
- lysidicin B [MeSH Supplementary Concept]
- lysidicin C [MeSH Supplementary Concept]
- lysidicin F [MeSH Supplementary Concept]
- lysidicin G [MeSH Supplementary Concept]
- lysidicin H [MeSH Supplementary Concept]
- macrocarpal A [MeSH Supplementary Concept]
- macrocarpal B [MeSH Supplementary Concept]
- macrocarpal C [MeSH Supplementary Concept]
- macrocarpal H [MeSH Supplementary Concept]
- macrocarpal I [MeSH Supplementary Concept]
- macrocarpal J [MeSH Supplementary Concept]
- mallotochromene [MeSH Supplementary Concept]
- mallotojaponin [MeSH Supplementary Concept]
- mallotojaponin B [MeSH Supplementary Concept]
- mallotojaponin C [MeSH Supplementary Concept]
- mallotus B [MeSH Supplementary Concept]
- monoacetylphloroglucinol [MeSH Supplementary Concept]
- moronone [MeSH Supplementary Concept]
- myrtucommulone A [MeSH Supplementary Concept]
- myrtucommulone B [MeSH Supplementary Concept]
- myrtucommulone K [MeSH Supplementary Concept]
- olympicin A [MeSH Supplementary Concept]
- papuaforin A [MeSH Supplementary Concept]
- papuaforin B [MeSH Supplementary Concept]
- papuaforin C [MeSH Supplementary Concept]
- petiolin A [MeSH Supplementary Concept]
- petiolin B [MeSH Supplementary Concept]
- petiolin C [MeSH Supplementary Concept]
- petiolin J [MeSH Supplementary Concept]
- phlorin phloroglucinol [MeSH Supplementary Concept]
- phloroglucinol dimethyl ether [MeSH Supplementary Concept]
- polyphloroglucinol phosphate [MeSH Supplementary Concept]
- prolifenone A [MeSH Supplementary Concept]
- prolifenone B [MeSH Supplementary Concept]
- prolificin A [MeSH Supplementary Concept]
- protokosin [MeSH Supplementary Concept]
- psidosone A [MeSH Supplementary Concept]
- retroflexanone [MeSH Supplementary Concept]
- sargassumol [MeSH Supplementary Concept]
- saroaspidin A [MeSH Supplementary Concept]
- saroaspidin B [MeSH Supplementary Concept]
- saroaspidin C [MeSH Supplementary Concept]
- sarothralin G [MeSH Supplementary Concept]
- secohyperforin [MeSH Supplementary Concept]
- selancin A [MeSH Supplementary Concept]
- semimyrtucommulone [MeSH Supplementary Concept]
- sideroxylonal C [MeSH Supplementary Concept]
- sinapyl acetate [MeSH Supplementary Concept]
- spiranthenone A [MeSH Supplementary Concept]
- spiranthenone B [MeSH Supplementary Concept]
- sundaicumone A [MeSH Supplementary Concept]
- sundaicumone B [MeSH Supplementary Concept]
- tomentosone A [MeSH Supplementary Concept]
- tomentosone B [MeSH Supplementary Concept]
- trinitrophloroglucinate [MeSH Supplementary Concept]
- trinitrophloroglucinol [MeSH Supplementary Concept]
- triphlorethol-A [MeSH Supplementary Concept]
- uliginosin A [MeSH Supplementary Concept]
- uliginosin B [MeSH Supplementary Concept]
- uralodin A [MeSH Supplementary Concept]
- vidalol A [MeSH Supplementary Concept]
- vidalol B [MeSH Supplementary Concept]
- yariv reagent [MeSH Supplementary Concept]
Semantic type(s)
- Indicator, Reagent, or Diagnostic Aid [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Phloroglucinol (substance) [SNOMED CT concept]
- phloroglucinol [ATC Code]
- phloroglucinol [Substance BNPC]
- phloroglucinol [International Nonproprietary Name]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients